Project Grant R01AI184920
Award Date
1/17/25
Completion Date
12/31/29
Dollars Obligated
$453K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $242,185 to Texas A&M AgriLife Research to conduct research on the role of RNA structure in the developmental regulation of RNA editing in trypanosomes, a group of pathogenic kinetoplastids. The primary objectives of this 2-year research project are to: 1) Develop a targeted mitochondrial DMS-MAPseq approach to...
This federal Project Grant award, totaling $791,864 and running from December 1, 2024 to November 30, 2029, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The primary goal of the research project is to identify the molecular factors that control chromatin organization and gene regulation in the Plasmodium falciparum parasite, the causative agent of the most severe form of human malaria....
This three-year, five-hundred twenty-three thousand four-hundred sixty-one dollar project grant from the National Science Foundation's Division of Molecular and Cellular Biosciences will fund research into RNA processing in trypanosome mitochondria. The grant was awarded to Seattle Children's Research Institute on April 1, 2022 and will be completed by March 31, 2025. The project aims to advance understanding of gene expression regulation in trypanosomes, single-celled parasites that alternate...
This federal Project Grant award of $942,886 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to investigate trypanosome cAMP signaling and its role in parasite-vector interactions for the African trypanosomiasis disease transmitted by the tsetse fly. The primary awardee, the University of California, Los Angeles (UCLA), is leading a multidisciplinary research effort to: 1) identify tsetse fly-derived...
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to study protein glycosylation and trafficking in the malaria parasite Plasmodium falciparum. The total funding amount is $1,333,629.00, spanning from the award date of June 6, 2024 to the ultimate completion date of April 30, 2029. The research project will combine genetic and cellular assays to investigate...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $441,502 to the University of Texas Health Science Center at Houston to advance CRISPR-based genome editing strategies for managing Aedes aegypti mosquito populations. The key research aims are: 1) Designing a CAS12 temperature-dependent system that requires only one strain containing both CAS12A and guide-RNAs...
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research focused on developing methods to genetically manipulate and grow in axenic (cell-free) media the tick-borne bacterial pathogens Ehrlichia chaffeensis and Anaplasma phagocytophilum. The total funding amount is $1,019,807, with the award period running from July 15, 2024 through May 31, 2029....
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $375,988 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Whitehead Institute for Biomedical Research. The purpose of this 3-year research project is to investigate the molecular mechanisms underlying the transition and reactivation of the chronic stage of the Toxoplasma gondii parasite. The research aims to uncover how a specific transcription factor (BFD1) and an upstream...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $215,751.00 to the Regents of the University of California at Riverside to identify and characterize RNA-binding proteins (RBPs) and RNA-dependent proteins (RDPs) in the malaria parasite Plasmodium falciparum. The key goals are to elucidate the importance of these proteins in parasite development,...
This Project Grant award, with a total funding of $246,024, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The award supports research to understand the molecular mechanisms underlying artemisinin drug resistance in the malaria-causing parasite Plasmodium falciparum. Key objectives include using advanced genomic techniques to elucidate the genetic signatures and transcriptional signatures...